Patent Assignment
Reel/Frame 012312/0544
Change of Name
Recorded: 2001-11-26
Pages: 8
Assignor
EDWARD MENDELL CO., INC.
Executed: 1997-10-31
Assignee
PENWEST PHARMACEUTICALS CO.
2981 ROUTE 22, PATTERSON, NEW YORK, 12563
Covered Property
(1)
Controlled Release Oxybutynin Formulations
Patent:
5,399,359 →
Application:
08/206,416 →
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Jan 22, 2002
From: ENDO PHARMACEUTICALS INC.
To: JPMORGAN CHASE BANK
Reel/Frame 012463/0709 →
License
Oct 30, 2009
From: PENWEST PHARMACEUTICALS COMPANY
To: ENDO PHARMACEUTICALS INC.
Reel/Frame 023449/0241 →
Confirmatory Grant of Security Interest in United States Patents (Exclusively Licensed Patents)
Feb 13, 2010
From: ENDO PHARMACEUTICALS INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 023928/0628 →
Release of Security Interest Recorded at Reel/Frame 23928/628
Dec 9, 2010
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ENDO PHARMACEUTICALS INC.
Reel/Frame 025456/0778 →
Security Agreement
Jul 8, 2011
From: PENWEST PHARMACEUTICALS CO.
To: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
Reel/Frame 026561/0701 →
Release of Patent Security Interest
Mar 3, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: PENWEST PHARMACEUTICALS CO.
Reel/Frame 032380/0963 →